Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An undifferentiated soft tissue sarcoma characterized by the presence of uniform round or ovoid malignant cells with a high nuclear to cytoplasmic ratio.
Biomarker and diagnostic research for undifferentiated round cell sarcoma has been reported in the published literature.
2 clinical trials registered. Interventions under study include other interventions, drug therapy, and procedural interventions. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
21 publications have been identified in PubMed for undifferentiated round cell sarcoma. Research spans Case Report / Case Series (48%), Review / Meta-Analysis (24%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 10:41 PM UTC
Research summaries | 5 | 24% |
Testing and diagnosis research | 2 | 10% |
Laboratory research | 2 | 10% |
Other research | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Angulo KRA (2026). [PMID: 42080670](https://pubmed.ncbi.nlm.nih.gov/42080670/). *Genes Chromosomes Cancer*. [Other]
Meet S (2026). [PMID: 41735791](https://pubmed.ncbi.nlm.nih.gov/41735791/). *Diagn Cytopathol*. [Diagnostic / Biomarker]
O'Connor P (2026). [PMID: 41918274](https://pubmed.ncbi.nlm.nih.gov/41918274/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Chaudhary Y (2026). [PMID: 42181466](https://pubmed.ncbi.nlm.nih.gov/42181466/). *Cureus*. [Case Report / Case Series]
Marcelis L (2025). [PMID: 39510958](https://pubmed.ncbi.nlm.nih.gov/39510958/). *Ann Pathol*. [Review / Meta-Analysis]
Mandim A (2025). [PMID: 40525058](https://pubmed.ncbi.nlm.nih.gov/40525058/). *Cureus*. [Case Report / Case Series]
Cloutier JM (2025). [PMID: 39921488](https://pubmed.ncbi.nlm.nih.gov/39921488/). *J Cutan Pathol*. [Review / Meta-Analysis]
Thirunavukkarasu B (2025). [PMID: 40693581](https://pubmed.ncbi.nlm.nih.gov/40693581/). *Appl Immunohistochem Mol Morphol*. [Case Report / Case Series]
Mezri S (2025). [PMID: 37997639](https://pubmed.ncbi.nlm.nih.gov/37997639/). *Ear Nose Throat J*. [Case Report / Case Series]
Ishibashi S (2025). [PMID: 40799881](https://pubmed.ncbi.nlm.nih.gov/40799881/). *Cureus*. [Case Report / Case Series]
AI-curated news mentioning undifferentiated round cell sarcoma
Updated Sep 4, 2026
A recent study expands the understanding of undifferentiated round cell sarcoma with the CIC::NUTM1 fusion, highlighting its clinicopathologic features. This research contributes to the growing knowledge of rare molecular variants in CIC-rearranged sarcomas.